Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. for allegedly misleading investors regarding the company's competitive position and financial performance during the class period from March 5, 2024, to October 28, 2025 [1][3]. Group 1: Allegations Against Avantor - The complaint alleges that Avantor and its executives violated federal securities laws by making false and misleading statements about the company's competitive positioning and failing to disclose the negative impacts of increased competition [3]. - Defendants misled investors by downplaying the effects of competition, claiming that Avantor's lab business was performing well and that the company had strong competitive advantages [4]. Group 2: Financial Performance and Stock Impact - On April 25, 2025, Avantor reported disappointing Q1 2025 results, cutting its guidance and announcing the resignation of CEO Michael Stubblefield, leading to a stock price decline of $2.57 (over 16.5%) from $15.50 to $12.93 [5]. - The company continued to report weak financial results, including a year-over-year decrease in net sales and a further reduction in guidance, resulting in a stock price drop of $2.08 (over 15%) from $13.44 to $11.36 on August 1, 2025 [6]. - On October 29, 2025, Avantor reported a net loss of $712 million and -5% organic revenue growth, leading to a significant stock price decline of $3.50 (over 23%) from $15.08 to $11.58 [7][8].
AVTR DEADLINE: Faruqi & Faruqi Reminds Avantor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 29, 2025 - AVTR